A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers
D. Ross Camidge, Dominic Smethurst, Jim Growcott, Nigel C. Barrass, John R. Foster, Salvatore Febbraro, Helen Swaisland, Andrew HughesТом:
60
Мова:
english
Сторінки:
8
DOI:
10.1007/s00280-006-0371-x
Date:
August, 2007
Файл:
PDF, 324 KB
english, 2007